{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:47:39Z","timestamp":1790340459059,"version":"4.1.0"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00403","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T04:37:47Z","timestamp":1592887067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K\/Akt Pathway Provide Clues?"],"prefix":"10.3389","volume":"11","author":[{"given":"Rachel M.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M. P.","family":"Holly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina M.","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley J.","family":"Allen-Birt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Perks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","unstructured":""},{"key":"B3","unstructured":""},{"key":"B4","unstructured":""},{"key":"B5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12883-016-0765-2","article-title":"Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review","volume":"16","author":"Shafi","year":"2016","journal-title":"BMC Neurol"},{"key":"B6","unstructured":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer's disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","article-title":"The amyloid cascade hypothesis in Alzheimer's disease: it's time to change our mind","volume":"15","author":"Ricciarelli","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnins.2019.00155","article-title":"Alzheimer's disease and cancer: when two monsters cannot be together","volume":"13","author":"Majd","year":"2019","journal-title":"Front Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-121867","article-title":"Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia","volume":"35","author":"Mosconi","year":"2013","journal-title":"J Alzheimers Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1001\/jama.298.22.2654","article-title":"Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis","volume":"298","author":"Willi","year":"2007","journal-title":"JAMA."},{"key":"B24","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.jada.2009.08.014","article-title":"Weighty concerns: the growing prevalence of obesity among older adults","volume":"109","author":"Houston","year":"2009","journal-title":"J Am Diet Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2337\/dc10-0879","article-title":"Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006","volume":"34","author":"Mozumdar","year":"2011","journal-title":"Diabetes Care."},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul Health Metr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E846","DOI":"10.1152\/ajpendo.1991.260.6.E846","article-title":"Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes","volume":"260","author":"Boni-Schnetzler","year":"1991","journal-title":"Am J Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1210\/jcem.74.6.1375600","article-title":"Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans","volume":"74","author":"Conover","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ecl.2012.04.017","article-title":"Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes","volume":"41","author":"Clemmons","year":"2012","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1042\/bj2900419","article-title":"Purified hybrid insulin\/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity","volume":"290","author":"Soos","year":"1993","journal-title":"Biochem J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"39684","DOI":"10.1074\/jbc.M202766200","article-title":"Insulin\/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved","volume":"277","author":"Pandini","year":"2002","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1210\/en.2011-1843","article-title":"Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway","volume":"153","author":"Malaguarnera","year":"2012","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1054\/ghir.2002.0264","article-title":"Insulin and insulin-like growth factors: the paradox of signaling specificity","volume":"12","author":"De Meyts","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12551-015-0186-2","article-title":"Glucose transporters: physiological and pathological roles","volume":"8","author":"Navale","year":"2016","journal-title":"Biophys Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10059-013-0140-8","article-title":"Autophagy: a critical regulator of cellular metabolism and homeostasis","volume":"36","author":"Ryter","year":"2013","journal-title":"Mol Cells."},{"key":"B39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/med.21531","article-title":"The multifaceted role of autophagy in cancer and the microenvironment","volume":"39","author":"Folkerts","year":"2019","journal-title":"Med Res Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fnmol.2019.00203","article-title":"Targeting autophagy for the treatment of alzheimer's disease: challenges and opportunities","volume":"12","author":"Liu","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies","volume":"11","author":"Key","year":"2010","journal-title":"Lancet Oncol."},{"key":"B42","first-page":"1935","article-title":"Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin\/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling","volume":"5","author":"Pandini","year":"1999","journal-title":"Clin Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","article-title":"Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival","volume":"68","author":"Law","year":"2008","journal-title":"Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1248\/bpb.34.1774","article-title":"Receptor tyrosine kinases and targeted cancer therapeutics","volume":"34","author":"Takeuchi","year":"2011","journal-title":"Biol Pharm Bull."},{"key":"B45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/329301a0","article-title":"Insulin-like growth factor II receptor as a multifunctional binding protein","volume":"329","author":"Morgan","year":"1987","journal-title":"Nature."},{"key":"B46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/ng1295-447","article-title":"M6P\/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity","volume":"11","author":"De Souza","year":"1995","journal-title":"Nat Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0002-9440(10)62335-8","article-title":"Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells","volume":"166","author":"Hartmann","year":"2005","journal-title":"Am J Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1258\/ebm.2009.009251","article-title":"Genomic imprinting: the influence of differential methylation in the two sexes","volume":"235","author":"Biliya","year":"2010","journal-title":"Exp Biol Med (Maywood)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1038\/sj.onc.1210397","article-title":"IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells","volume":"26","author":"Perks","year":"2007","journal-title":"Oncogene."},{"key":"B50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1309\/AJCPR11DEAYPTUSL","article-title":"Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer","volume":"141","author":"Dean","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell."},{"key":"B53","first-page":"8","article-title":"Dynamic adaptation of nutrient utilization in humans","volume":"3","author":"El Bacha","year":"2010","journal-title":"Nat Educ"},{"key":"B54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin resistance and alzheimer's disease: bioenergetic linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1523\/JNEUROSCI.1700-16.2016","article-title":"Novel roles for the insulin-regulated glucose transporter-4 in hippocampally dependent memory","volume":"36","author":"Pearson-Leary","year":"2016","journal-title":"J Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.euroneuro.2014.01.020","article-title":"Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects","volume":"24","author":"Werner","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1178626419842176","DOI":"10.1177\/1178626419842176","article-title":"The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system","volume":"12","author":"Lewitt","year":"2019","journal-title":"Biochem Insights."},{"key":"B59","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J Neural Transm (Vienna)."},{"key":"B60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1749-6632.1999.tb07839.x","article-title":"A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease","volume":"893","author":"Frolich","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jnnp.2003.030882","article-title":"Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve","volume":"76","author":"Mosconi","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B62","first-page":"1778","article-title":"Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease","volume":"47","author":"Mosconi","year":"2006","journal-title":"J Nucl Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2014.05.001","article-title":"Early detection of Alzheimer's disease using PiB and FDG PET","volume":"72","author":"Cohen","year":"2014","journal-title":"Neurobiol Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J Exp Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-211-73574-9_28","article-title":"Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach","volume":"72","author":"Salkovic-Petrisic","year":"2007","journal-title":"J Neural Transm Suppl"},{"key":"B70","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2017.09.016","article-title":"Reduced brain insulin signaling: a seminal process in Alzheimer's disease pathogenesis","volume":"136","author":"Bloom","year":"2018","journal-title":"Neuropharmacology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/cns.12866","article-title":"Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment","volume":"24","author":"Pomytkin","year":"2018","journal-title":"CNS Neurosci Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol Aging."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exger.2014.10.002","article-title":"Growth hormone, insulin-like growth factor-1 and the aging brain","volume":"68","author":"Ashpole","year":"2015","journal-title":"Exp Gerontol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3748\/wjg.v11.i13.1891","article-title":"Role of insulin\/insulin-like growth factor 1 signaling pathway in longevity","volume":"11","author":"Cheng","year":"2005","journal-title":"World J Gastroenterol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front Neurosci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12035-012-8313-6","article-title":"Beta-amyloid monomer and insulin\/IGF-1 signaling in Alzheimer's disease","volume":"46","author":"Giuffrida","year":"2012","journal-title":"Mol Neurobiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1471-4159.2004.02889.x","article-title":"Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of beta-amyloid-treated rats","volume":"92","author":"Aguado-Llera","year":"2005","journal-title":"J Neurochem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.neurobiolaging.2005.06.015","article-title":"Therapeutic actions of insulin-like growth factor I on APP\/PS2 mice with severe brain amyloidosis","volume":"27","author":"Carro","year":"2006","journal-title":"Neurobiol Aging."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0155733","DOI":"10.1371\/journal.pone.0155733","article-title":"Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease","volume":"11","author":"Ostrowski","year":"2016","journal-title":"PLoS ONE."},{"key":"B83","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4161\/cc.6.6.4035","article-title":"Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2","volume":"6","author":"Dearth","year":"2007","journal-title":"Cell Cycle."},{"key":"B84","doi-asserted-by":"publisher","first-page":"S494","DOI":"10.4103\/0973-1482.181180","article-title":"The expression of insulin receptor substrate 1 and estrogen receptor as prognostic factor on breast cancer patient","volume":"14","author":"Kim","year":"2018","journal-title":"J Cancer Res Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia."},{"key":"B86","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1158\/1940-6207.CAPR-09-0199","article-title":"Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma","volume":"3","author":"McCampbell","year":"2010","journal-title":"Cancer Prev Res (Phila)."},{"key":"B87","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B88","first-page":"1367","article-title":"Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis","volume":"56","author":"Zhang","year":"1996","journal-title":"Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.tem.2006.06.007","article-title":"The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action","volume":"17","author":"Werner","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/377646a0","article-title":"Induction of the growth inhibitor IGF-binding protein 3 by p53","volume":"377","author":"Buckbinder","year":"1995","journal-title":"Nature."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","article-title":"The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression","volume":"64","author":"Schwartzenberg-Bar-Yoseph","year":"2004","journal-title":"Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/bcr426","article-title":"The p53 pathway in breast cancer","volume":"4","author":"Gasco","year":"2002","journal-title":"Breast Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/em.10065","article-title":"p53 as a mutagen test in breast cancer","volume":"39","author":"Hill","year":"2002","journal-title":"Environ Mol Mutagen."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/sj.bjc.6690628","article-title":"Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis","volume":"80","author":"Pharoah","year":"1999","journal-title":"Br J Cancer."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/ijms17091495","article-title":"Physiological and pathogenic roles of prolyl isomerase pin1 in metabolic regulations via multiple signal transduction pathway modulations","volume":"17","author":"Nakatsu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3389\/fphar.2018.01477","article-title":"A Guide to PIN1 function and mutations across cancers","volume":"9","author":"El Boustani","year":"2018","journal-title":"Front Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/cr.2014.109","article-title":"Prolyl isomerase Pin1 in cancer","volume":"24","author":"Lu","year":"2014","journal-title":"Cell Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"20812","DOI":"10.1074\/jbc.M110.206904","article-title":"Peptidyl-prolyl cis\/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis","volume":"286","author":"Nakatsu","year":"2011","journal-title":"J Biol Chem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1038\/onc.2009.98","article-title":"Peptidyl-prolyl cis\/trans isomerase Pin1 is critical for the regulation of PKB\/Akt stability and activation phosphorylation","volume":"28","author":"Liao","year":"2009","journal-title":"Oncogene."},{"key":"B100","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fnmol.2019.00242","article-title":"Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression","volume":"12","author":"Baquero","year":"2019","journal-title":"Front Mol Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2011.06.004","article-title":"A Pin1\/mutant p53 axis promotes aggressiveness in breast cancer","volume":"20","author":"Girardini","year":"2011","journal-title":"Cancer Cell."},{"key":"B102","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/cdd.2016.122","article-title":"PIN1 in breast development and cancer: a clinical perspective","volume":"24","author":"Rustighi","year":"2017","journal-title":"Cell Death Differ"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1158\/0008-5472.CAN-12-4360","article-title":"SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function","volume":"73","author":"Chen","year":"2013","journal-title":"Cancer Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1074\/jbc.275.4.2777","article-title":"BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression","volume":"275","author":"MacLachlan","year":"2000","journal-title":"J Biol Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nat Cell Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nbd.2005.11.002","article-title":"Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease","volume":"22","author":"Butterfield","year":"2006","journal-title":"Neurobiol Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","article-title":"Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol Aging."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3270725","DOI":"10.1155\/2017\/3270725","article-title":"Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease","volume":"2017","author":"Xu","year":"2017","journal-title":"Neural Plast."},{"key":"B109","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0969-9961(03)00109-8","article-title":"Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies","volume":"14","author":"Ramakrishnan","year":"2003","journal-title":"Neurobiol Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"16775","DOI":"10.1074\/jbc.M110.212878","article-title":"Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor","volume":"286","author":"Woldt","year":"2011","journal-title":"J Biol Chem."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1523\/JNEUROSCI.5180-14.2015","article-title":"Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain","volume":"35","author":"Liu","year":"2015","journal-title":"J Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"8356537","DOI":"10.1155\/2017\/8356537","article-title":"The LDL Receptor-Related Protein 1: At the Crossroads of Lipoprotein Metabolism and Insulin Signaling","volume":"2017","author":"Au","year":"2017","journal-title":"J Diabetes Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/glia.23009","article-title":"Low-density lipoprotein receptor-related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation","volume":"64","author":"Safina","year":"2016","journal-title":"Glia."},{"key":"B114","first-page":"365","article-title":"Decreased expression of the low density lipoprotein receptor-related protein\/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells","volume":"6","author":"Kancha","year":"1994","journal-title":"Oncol Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-08-4573","article-title":"The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression","volume":"69","author":"Fayard","year":"2009","journal-title":"Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.humpath.2011.01.011","article-title":"Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2\/neu and triple-negative breast carcinomas","volume":"42","author":"Catasus","year":"2011","journal-title":"Hum Pathol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1158\/0008-5472.CAN-08-3379","article-title":"Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e1000575","DOI":"10.1371\/journal.pbio.1000575","article-title":"Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system","volume":"9","author":"Liu","year":"2011","journal-title":"PLoS Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/78693","article-title":"Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance","volume":"6","author":"Zisman","year":"2000","journal-title":"Nat Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/09687680110072131","article-title":"GLUT4: a key player regulating glucose homeostasis?","volume":"18","author":"Wallberg-Henriksson","year":"2001","journal-title":"Mol Membr Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","article-title":"Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J Neuropathol Exp Neurol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J Clin Invest."},{"key":"B124","doi-asserted-by":"publisher","first-page":"34045","DOI":"10.1074\/jbc.M109.021030","article-title":"Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway","volume":"284","author":"Fuentealba","year":"2009","journal-title":"J Biol Chem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: there and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fcell.2019.00322","article-title":"Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms","volume":"7","author":"Huang","year":"2019","journal-title":"Front Cell Dev Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1385\/JMN:19:3:275","article-title":"Pin1: a therapeutic target in Alzheimer neurodegeneration","volume":"19","author":"Hamdane","year":"2002","journal-title":"J Mol Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fphar.2015.00271","article-title":"The matricellular receptor LRP1 forms an interface for signaling and endocytosis in modulation of the extracellular tumor environment","volume":"6","author":"Van Gool","year":"2015","journal-title":"Front Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s11095-017-2267-3","article-title":"endothelial lrp1 - a potential target for the treatment of alzheimer's disease : theme: drug discovery, development and delivery in alzheimer's disease guest editor: davide brambilla","volume":"34","author":"Storck","year":"2017","journal-title":"Pharm Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fendo.2015.00074","article-title":"Preclinical Effectiveness of Selective Inhibitor of IRS-1\/2 NT157 in Osteosarcoma Cell Lines","volume":"6","author":"Garofalo","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B131","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s12276-018-0099-9","article-title":"An MG53-IRS1-interaction disruptor ameliorates insulin resistance","volume":"50","author":"Park","year":"2018","journal-title":"Exp Mol Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13046-018-0705-7","article-title":"New therapeutic strategies to treat human cancers expressing mutant p53 proteins","volume":"37","author":"Blandino","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pneurobio.2018.05.001","article-title":"The interactions of p53 with tau and Ass as potential therapeutic targets for Alzheimer's disease","volume":"168","author":"Jazvinscak Jembrek","year":"2018","journal-title":"Prog Neurobiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2050312119865114","DOI":"10.1177\/2050312119865114","article-title":"Metformin as an adjuvant in breast cancer treatment","volume":"7","author":"Roshan","year":"2019","journal-title":"SAGE Open Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000106378","article-title":"Intranasal insulin to improve memory function in humans","volume":"86","author":"Benedict","year":"2007","journal-title":"Neuroendocrinology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/CMAR.S200059","article-title":"The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances","volume":"11","author":"Saraei","year":"2019","journal-title":"Cancer Manag Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J Alzheimers Dis."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00403\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T04:37:54Z","timestamp":1592887074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00403\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":137,"alternative-id":["10.3389\/fendo.2020.00403"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00403","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"article-number":"403"}}